Filing Details

Accession Number:
0001415889-21-003128
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-21 18:52:14
Reporting Period:
2021-06-16
Accepted Time:
2021-06-21 18:52:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1646649 Jonathan Sheena C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-16 11,670 $101.12 462,465 No 4 S Direct
Common Stock Disposition 2021-06-17 2,100 $101.54 460,365 No 4 S Direct
Common Stock Disposition 2021-06-17 1,000 $102.55 459,365 No 4 S Direct
Common Stock Disposition 2021-06-17 4,075 $103.47 455,290 No 4 S Direct
Common Stock Disposition 2021-06-17 155 $104.16 455,135 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.00 to $101.28 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.02 to $101.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.02 to $102.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.07 to $104.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.11 to $104.18 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.